Sarepta Therapeutics (SRPT) Gross Margin Growth (5y) (2022 - 2026)

Sarepta Therapeutics (SRPT) Gross Margin Growth (5y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Sarepta Therapeutics 1.91 Bn 1.12 Bn 251.87 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,534.00
Mar 31, 2026 33.00
Dec 31, 2025 -7,458.00
Sep 30, 2025 -2,539.00
Jun 30, 2025 -1,525.00
Mar 31, 2025 -9,207.00
Dec 31, 2024 -454.00
Sep 30, 2024 -646.00
Jun 30, 2024 454.00
Mar 31, 2024 164.00
Dec 31, 2023 1,146.00
Sep 30, 2023 -83.00
Jun 30, 2023 -390.00
Mar 31, 2023 -649.00
Dec 31, 2022 264.00
Sep 30, 2022 -1,065.00
Jun 30, 2022 -1,645.00
Mar 31, 2022 -1,528.00